Waters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow WAT
Waters Corporation (WAT) Revenue growth
Waters Corporation's revenue growth over the twelve months to 30 June 2026 was 52.5%, up 45.5 percentage points from fiscal 2025 (6.99%). Over the past ten years it has ranged from −1.71% (fiscal 2020) to 17.8% (fiscal 2021); the current reading is higher than 91% of that period. That is above the Diagnostics & Research industry median of 7.69% and above the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 6.99% | 6.92 |
| FY2024 | 0.07% | 0.59 |
| FY2023 | −0.52% | (7.20) |
| FY2022 | 6.68% | (11.10) |
| FY2021 | 17.8% | 19.49 |
| FY2020 | −1.71% | (1.16) |
| FY2019 | −0.55% | (5.35) |
| FY2018 | 4.80% | (1.74) |
| FY2017 | 6.54% | 0.42 |
| FY2016 | 6.12% | 3.46 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 113.4% | 21.97 |
| Mar 2026 | 91.4% | 84.55 |
| Dec 2025 | 6.84% | (1.21) |
| Sep 2025 | 8.05% | (0.77) |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| WAT Waters Corporation | 52.5% |
| NTRA Natera, Inc. compare | 37.8% |
| IDXX IDEXX Laboratories, Inc. compare | 12.8% |
| DGX Quest Diagnostics Incorporated compare | 9.87% |
| A Agilent Technologies, Inc. compare | 8.60% |
| IQV IQVIA Holdings Inc. compare | 8.17% |
| MTD Mettler-Toledo International, Inc. compare | 6.91% |
| LH Labcorp Holdings Inc. compare | 6.41% |
| ILMN Illumina, Inc. compare | 4.88% |
| Diagnostics & Research industry median | 7.69% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on WAT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement